← Eichor
Study identifier: NCT06995534 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Splinting vs Exercise in De Quervain's Tenosynovitis

Condition: Splints · Exercise Therapy · De Quervains Tenosynovitis  ·  Sponsor: Konya Beyhekim Training and Research Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required. Currently, there is no standardized treatment protocol supported by strong, up-to-date evidence. The aim of this study is to compare the effectiveness of a static hand-wrist resting splint and exercise therapy in the conservative treatment of De Quervain's tenosynovitis. Patients will be evaluated in terms of pain levels, functional/symptom status, hand-finger strength, pressure pain threshold (PPT), tendon cross-sectional area measured by ultrasound, and the presence of effusion findings (semiquantitative; 0-3), and patient satisfaction.

This description comes directly from the study's public registry record.

Talk to the study team

Eda Ünal Madıoğlu(MD)  ·  905530970738  ·  ade.1997.lanu@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Konya Beyhekim Training and Research HospitalKonya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06995534